Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Financials

Oaktree Acquisition Corp. III Life Sciences (OACC)

NGM · Shell Companies

$10.74+0.03 (+0.28%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$264.0M
P/E (TTM)
37.03
EPS
$0.29
Div Yield
52W Range
$10.30–$10.75
Beta

Company overview

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Peers in Shell Companies

All in industry →

Recent press releases

Oaktree Acquisition Corp. III Life Sciences has not issued a press release in this window.

SEC filings

All filings →

Oaktree Acquisition Corp. III Life Sciences has not filed an SEC document in this window.

Oaktree Acquisition Corp. III Life Sciences has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for Oaktree Acquisition Corp. III Life Sciences in this window.

People at Oaktree Acquisition Corp. III Life Sciences

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for Oaktree Acquisition Corp. III Life Sciences.